期刊文献+

肺癌的中医药维持治疗思路 被引量:18

TCM Maintenance Therapy for Lung Cancer
原文传递
导出
摘要 随着现代化学治疗模式在肿瘤治疗领域的不断发展,维持治疗越来越受到重视,但也存在毒副作用较多、过度治疗、费用偏高等弊端。中医药在长期稳定瘤体,防止复发转移,改善远期生存率等方面具有优势。朴炳奎教授采用益气养阴清肺、化痰祛瘀散结、清热解毒通络等法,结合肺癌的中医辨证分型及病情发展特点,拟定了益气养阴、清热解毒为主的肺瘤平Ⅰ号方和益气养阴、活血化瘀、解毒抗癌为主的肺瘤平Ⅱ号方用于肺癌的维持治疗。 The maintenance therapy is valued with the development of modern chemotherapy in cancer treatment, but there are still some defects such as side effects, over-treatment and high costs. Chinese medicine has advantages in stabling the tumor, preventing recurrence, and improving long-term survival. Dr. PIAO Bingkui has developed Feiliuping I Formula and Feiliuping H Formula for the maintenance treatment of lung cancer with qi-supplementing yin-nourishing lung-cleating method, phlegm-transforming, stasis-dispelling and bind-dissipating method and heatcleating, toxin-resolving and network vessels-freeing method based on traditional Chinese medicine pattern identification.
出处 《中医杂志》 CSCD 北大核心 2014年第4期295-298,共4页 Journal of Traditional Chinese Medicine
基金 中国中医科学院名医名家传承项目资助(CM20121002)
关键词 肺癌 维持治疗 traditional Chinese medicine lung cancer maintenance treatment Feiliuping Paste PIAO Bingkui
  • 相关文献

参考文献19

  • 1Owonikoko TK, Ramalingam SS, Belani CP. Maintenance therapy for advanced non-small cell lung cancer: current status, controversies, and emerging consensus [ J ]. Clin Cancer Res,2010,16 (9) :2496 - 2504.
  • 2Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate [J]. Cancer Treat Rep, 1979,63 ( 11 - 12) : 1727 - 1733.
  • 3李慧杰,齐元富,李秀荣.中医药维持治疗晚期非小细胞肺癌的可行性探讨[J].中国肿瘤,2012,21(11):845-847. 被引量:27
  • 4Ciuleanu T, Brodowicz T, Zielinski C, et al. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell tung cancer: a ran- domised, double-blind, phase 3 study [ J ]. Lancet, 2009, 374 (9699) :1432 - 1440.
  • 5Brodowicz T, Krzakowski M, Zwitter M, et at. Cisplatin and gemcitabine first-line chemotherapy followed by mainte- nance gemcitabine or best supportive care in advanced non- small cell lung cancer:a phase Ⅲ trial [ J]. Lung Cancer, 2006,52(2) : 155 - 163.
  • 6Muir VJ, Dhillon S. Erlotinib : as maintenance monotherapy in non-small-cell lung cancer[ J]. BioDrugs,2011,25 (3) : 139 - 146.
  • 7Takeda K,Hida T,Sato T,et al. Randomized phase Ⅲ trial of platinum-doublet chemotherapy followed by gefitinib com- pared with continued platinum-doublet chemotherapy in Japanese patients with advanced notl-small-cell lung cancer: results of a west Japan thoracic oncology group trial (WJTOG0203) [J]. J Clin Oncol,2010,28(5) :753 -760.
  • 8柴小姝,何春霞,吴万垠,李柳宁.消积饮维持治疗晚期非小细胞肺癌对生存期的影响[J].时珍国医国药,2011,22(10):2547-2548. 被引量:15
  • 9刘志臻,余宗阳,欧阳学农,戴西湖,陈曦,赵忠全,王文武,李捷,涂华,叶磊,颜艳.肺泰胶囊维持治疗对中晚期非小细胞肺癌无进展生存期的影响[J].临床肿瘤学杂志,2009,14(4):344-346. 被引量:33
  • 10姜怡,刘苓霜,李春杰,田建辉,沈丽萍,李和根.中医综合方案维持治疗晚期非小细胞肺癌对疾病进展时间和生活质量的影响[J].中国中西医结合杂志,2011,31(10):1311-1316. 被引量:45

二级参考文献90

共引文献375

同被引文献198

引证文献18

二级引证文献215

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部